Antitumor characteristics of methoxypolyethylene glycol–poly(dl-lactic acid) nanoparticles containing camptothecin

The novel nanoparticles (CPT-NP) were prepared by the solvent evaporation method using methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer as a matrix and camptothecin (CPT) as an antitumor agent, and the antitumor characteristics were examined in vitro and in vivo. The mean diameter of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2004-05, Vol.97 (1), p.101-113
Hauptverfasser: Miura, Hidetaka, Onishi, Hiraku, Sasatsu, Masanaho, Machida, Yoshiharu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 113
container_issue 1
container_start_page 101
container_title Journal of controlled release
container_volume 97
creator Miura, Hidetaka
Onishi, Hiraku
Sasatsu, Masanaho
Machida, Yoshiharu
description The novel nanoparticles (CPT-NP) were prepared by the solvent evaporation method using methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer as a matrix and camptothecin (CPT) as an antitumor agent, and the antitumor characteristics were examined in vitro and in vivo. The mean diameter of CPT-NP was approximately 250 nm. The drug release from CPT-NP in phosphate-buffered saline, pH 7.4, depended on the particle concentration; in the diluted condition, the initial rapid release was greater and subsequent gradual release was faster. After i.v. administration (0.5 mg CPT eq./kg) in rats, CPT-NP showed a longer plasma retention than CPT solution. In both single (2.5 mg CPT eq./kg) and double (2.5 mg CPT eq./kg×2) administration to mice bearing sarcoma 180 solid tumor, CPT-NP were much more effective than CPT solution; especially, the tumor disappeared completely in three of the four mice in twice administration of CPT-NP, when the body weight did not decrease markedly. After i.v. administration to the tumor-bearing mice, CPT-NP showed better plasma retention, and high and long tumor localization. CPT-NP are suggested to greatly improve the efficacy of CPT due to their pharmacokinetic features.
doi_str_mv 10.1016/j.jconrel.2004.03.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71930825</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365904001282</els_id><sourcerecordid>17568164</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-11a1aca29f56dda9c02d95fcf6ce67c4974514223ad6961082e1a78015ff842e3</originalsourceid><addsrcrecordid>eNqFkc-O1SAUh4nRONfRR9B0o9FFK7RQymoymfgvmcSNrgmens7lhkIFrrE738E39Enk5jbR3awgJ98PzjkfIc8ZbRhl_dtDc4DgI7qmpZQ3tGsoVQ_Ijg2yq7lS4iHZFW6ou16oC_IkpQOlVHRcPiYXTDAuBzrsSL722ebjHGIFexMNZIw2ZQupClM1Y96Hn-sS3Fpuq0OP1Z1bIbg_v36fqq9HV7sSslAZsOObyhsfFhNLwWGqSofZWG_9XQVmXnLIewTrn5JHk3EJn23nJfn6_t2Xm4_17ecPn26ub2vgbZtrxgwzYFo1iX4cjQLajkpMMPWAvQSuJC9ztG1nxl71jA4tMlPGYmKaBt5id0lend9dYvh-xJT1bBOgc8ZjOCYtmepKStwLMin6gfW8gOIMQgwpRZz0Eu1s4qoZ1Scv-qA3L_rkRdNOFy8l92L74PhtxvFfahNRgJcbYBIYN0Xjwab_ODkMUnaFuzpzWPb2w2LUCSx6wNFGhKzHYO9p5S8TCLJo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17568164</pqid></control><display><type>article</type><title>Antitumor characteristics of methoxypolyethylene glycol–poly(dl-lactic acid) nanoparticles containing camptothecin</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Miura, Hidetaka ; Onishi, Hiraku ; Sasatsu, Masanaho ; Machida, Yoshiharu</creator><creatorcontrib>Miura, Hidetaka ; Onishi, Hiraku ; Sasatsu, Masanaho ; Machida, Yoshiharu</creatorcontrib><description>The novel nanoparticles (CPT-NP) were prepared by the solvent evaporation method using methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer as a matrix and camptothecin (CPT) as an antitumor agent, and the antitumor characteristics were examined in vitro and in vivo. The mean diameter of CPT-NP was approximately 250 nm. The drug release from CPT-NP in phosphate-buffered saline, pH 7.4, depended on the particle concentration; in the diluted condition, the initial rapid release was greater and subsequent gradual release was faster. After i.v. administration (0.5 mg CPT eq./kg) in rats, CPT-NP showed a longer plasma retention than CPT solution. In both single (2.5 mg CPT eq./kg) and double (2.5 mg CPT eq./kg×2) administration to mice bearing sarcoma 180 solid tumor, CPT-NP were much more effective than CPT solution; especially, the tumor disappeared completely in three of the four mice in twice administration of CPT-NP, when the body weight did not decrease markedly. After i.v. administration to the tumor-bearing mice, CPT-NP showed better plasma retention, and high and long tumor localization. CPT-NP are suggested to greatly improve the efficacy of CPT due to their pharmacokinetic features.</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2004.03.009</identifier><identifier>PMID: 15147808</identifier><identifier>CODEN: JCREEC</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animals ; Antineoplastic Agents - pharmacokinetics ; Antineoplastic Agents - therapeutic use ; Antitumor effect ; Biological and medical sciences ; Camptothecin ; Camptothecin - pharmacokinetics ; Camptothecin - therapeutic use ; General pharmacology ; Lactic Acid - pharmacokinetics ; Lactic Acid - therapeutic use ; Male ; Medical sciences ; Methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer ; Mice ; Nanoparticle ; Nanostructures ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacokinetic feature ; Pharmacology. Drug treatments ; Polyethylene Glycols - pharmacokinetics ; Polyethylene Glycols - therapeutic use ; Rats ; Rats, Wistar ; Sarcoma 180 - drug therapy ; Sarcoma 180 - metabolism</subject><ispartof>Journal of controlled release, 2004-05, Vol.97 (1), p.101-113</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><rights>Coyright 2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-11a1aca29f56dda9c02d95fcf6ce67c4974514223ad6961082e1a78015ff842e3</citedby><cites>FETCH-LOGICAL-c422t-11a1aca29f56dda9c02d95fcf6ce67c4974514223ad6961082e1a78015ff842e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168365904001282$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15788773$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15147808$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miura, Hidetaka</creatorcontrib><creatorcontrib>Onishi, Hiraku</creatorcontrib><creatorcontrib>Sasatsu, Masanaho</creatorcontrib><creatorcontrib>Machida, Yoshiharu</creatorcontrib><title>Antitumor characteristics of methoxypolyethylene glycol–poly(dl-lactic acid) nanoparticles containing camptothecin</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>The novel nanoparticles (CPT-NP) were prepared by the solvent evaporation method using methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer as a matrix and camptothecin (CPT) as an antitumor agent, and the antitumor characteristics were examined in vitro and in vivo. The mean diameter of CPT-NP was approximately 250 nm. The drug release from CPT-NP in phosphate-buffered saline, pH 7.4, depended on the particle concentration; in the diluted condition, the initial rapid release was greater and subsequent gradual release was faster. After i.v. administration (0.5 mg CPT eq./kg) in rats, CPT-NP showed a longer plasma retention than CPT solution. In both single (2.5 mg CPT eq./kg) and double (2.5 mg CPT eq./kg×2) administration to mice bearing sarcoma 180 solid tumor, CPT-NP were much more effective than CPT solution; especially, the tumor disappeared completely in three of the four mice in twice administration of CPT-NP, when the body weight did not decrease markedly. After i.v. administration to the tumor-bearing mice, CPT-NP showed better plasma retention, and high and long tumor localization. CPT-NP are suggested to greatly improve the efficacy of CPT due to their pharmacokinetic features.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Antitumor effect</subject><subject>Biological and medical sciences</subject><subject>Camptothecin</subject><subject>Camptothecin - pharmacokinetics</subject><subject>Camptothecin - therapeutic use</subject><subject>General pharmacology</subject><subject>Lactic Acid - pharmacokinetics</subject><subject>Lactic Acid - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer</subject><subject>Mice</subject><subject>Nanoparticle</subject><subject>Nanostructures</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacokinetic feature</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyethylene Glycols - pharmacokinetics</subject><subject>Polyethylene Glycols - therapeutic use</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Sarcoma 180 - drug therapy</subject><subject>Sarcoma 180 - metabolism</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc-O1SAUh4nRONfRR9B0o9FFK7RQymoymfgvmcSNrgmens7lhkIFrrE738E39Enk5jbR3awgJ98PzjkfIc8ZbRhl_dtDc4DgI7qmpZQ3tGsoVQ_Ijg2yq7lS4iHZFW6ou16oC_IkpQOlVHRcPiYXTDAuBzrsSL722ebjHGIFexMNZIw2ZQupClM1Y96Hn-sS3Fpuq0OP1Z1bIbg_v36fqq9HV7sSslAZsOObyhsfFhNLwWGqSofZWG_9XQVmXnLIewTrn5JHk3EJn23nJfn6_t2Xm4_17ecPn26ub2vgbZtrxgwzYFo1iX4cjQLajkpMMPWAvQSuJC9ztG1nxl71jA4tMlPGYmKaBt5id0lend9dYvh-xJT1bBOgc8ZjOCYtmepKStwLMin6gfW8gOIMQgwpRZz0Eu1s4qoZ1Scv-qA3L_rkRdNOFy8l92L74PhtxvFfahNRgJcbYBIYN0Xjwab_ODkMUnaFuzpzWPb2w2LUCSx6wNFGhKzHYO9p5S8TCLJo</recordid><startdate>20040531</startdate><enddate>20040531</enddate><creator>Miura, Hidetaka</creator><creator>Onishi, Hiraku</creator><creator>Sasatsu, Masanaho</creator><creator>Machida, Yoshiharu</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20040531</creationdate><title>Antitumor characteristics of methoxypolyethylene glycol–poly(dl-lactic acid) nanoparticles containing camptothecin</title><author>Miura, Hidetaka ; Onishi, Hiraku ; Sasatsu, Masanaho ; Machida, Yoshiharu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-11a1aca29f56dda9c02d95fcf6ce67c4974514223ad6961082e1a78015ff842e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Antitumor effect</topic><topic>Biological and medical sciences</topic><topic>Camptothecin</topic><topic>Camptothecin - pharmacokinetics</topic><topic>Camptothecin - therapeutic use</topic><topic>General pharmacology</topic><topic>Lactic Acid - pharmacokinetics</topic><topic>Lactic Acid - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer</topic><topic>Mice</topic><topic>Nanoparticle</topic><topic>Nanostructures</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacokinetic feature</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyethylene Glycols - pharmacokinetics</topic><topic>Polyethylene Glycols - therapeutic use</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Sarcoma 180 - drug therapy</topic><topic>Sarcoma 180 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miura, Hidetaka</creatorcontrib><creatorcontrib>Onishi, Hiraku</creatorcontrib><creatorcontrib>Sasatsu, Masanaho</creatorcontrib><creatorcontrib>Machida, Yoshiharu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miura, Hidetaka</au><au>Onishi, Hiraku</au><au>Sasatsu, Masanaho</au><au>Machida, Yoshiharu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antitumor characteristics of methoxypolyethylene glycol–poly(dl-lactic acid) nanoparticles containing camptothecin</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2004-05-31</date><risdate>2004</risdate><volume>97</volume><issue>1</issue><spage>101</spage><epage>113</epage><pages>101-113</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><coden>JCREEC</coden><abstract>The novel nanoparticles (CPT-NP) were prepared by the solvent evaporation method using methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer as a matrix and camptothecin (CPT) as an antitumor agent, and the antitumor characteristics were examined in vitro and in vivo. The mean diameter of CPT-NP was approximately 250 nm. The drug release from CPT-NP in phosphate-buffered saline, pH 7.4, depended on the particle concentration; in the diluted condition, the initial rapid release was greater and subsequent gradual release was faster. After i.v. administration (0.5 mg CPT eq./kg) in rats, CPT-NP showed a longer plasma retention than CPT solution. In both single (2.5 mg CPT eq./kg) and double (2.5 mg CPT eq./kg×2) administration to mice bearing sarcoma 180 solid tumor, CPT-NP were much more effective than CPT solution; especially, the tumor disappeared completely in three of the four mice in twice administration of CPT-NP, when the body weight did not decrease markedly. After i.v. administration to the tumor-bearing mice, CPT-NP showed better plasma retention, and high and long tumor localization. CPT-NP are suggested to greatly improve the efficacy of CPT due to their pharmacokinetic features.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15147808</pmid><doi>10.1016/j.jconrel.2004.03.009</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2004-05, Vol.97 (1), p.101-113
issn 0168-3659
1873-4995
language eng
recordid cdi_proquest_miscellaneous_71930825
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Antineoplastic Agents - pharmacokinetics
Antineoplastic Agents - therapeutic use
Antitumor effect
Biological and medical sciences
Camptothecin
Camptothecin - pharmacokinetics
Camptothecin - therapeutic use
General pharmacology
Lactic Acid - pharmacokinetics
Lactic Acid - therapeutic use
Male
Medical sciences
Methoxypolyethylene glycol–poly(dl-lactic acid) block copolymer
Mice
Nanoparticle
Nanostructures
Pharmaceutical technology. Pharmaceutical industry
Pharmacokinetic feature
Pharmacology. Drug treatments
Polyethylene Glycols - pharmacokinetics
Polyethylene Glycols - therapeutic use
Rats
Rats, Wistar
Sarcoma 180 - drug therapy
Sarcoma 180 - metabolism
title Antitumor characteristics of methoxypolyethylene glycol–poly(dl-lactic acid) nanoparticles containing camptothecin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A11%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antitumor%20characteristics%20of%20methoxypolyethylene%20glycol%E2%80%93poly(dl-lactic%20acid)%20nanoparticles%20containing%20camptothecin&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Miura,%20Hidetaka&rft.date=2004-05-31&rft.volume=97&rft.issue=1&rft.spage=101&rft.epage=113&rft.pages=101-113&rft.issn=0168-3659&rft.eissn=1873-4995&rft.coden=JCREEC&rft_id=info:doi/10.1016/j.jconrel.2004.03.009&rft_dat=%3Cproquest_cross%3E17568164%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17568164&rft_id=info:pmid/15147808&rft_els_id=S0168365904001282&rfr_iscdi=true